FDA
label_change
· 2019-11-06
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for the amlodipine/atorvastatin combination by Mylan Pharmaceuticals, resulting in labeling changes to reflect the appro…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)